Clinical Trial Update: Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating mandatory second-look surgery with HIPEC and cytoreductive surgery for high-risk colorectal cancer with peritoneal metastase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Carcinomatosis

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Carcinoma, Peritoneal Carcinomatosis | Phase 2 | Status: WITHDRAWN